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Abstract
Background: During 2015–2016 an outbreak of invasive meningococcal disease due to N. meningitidis serogroup C ST-
11 (cc11) occurred in Tuscany, Italy. The outbreak affected mainly the age group 20–30 years, men who have sex with
men, and the area located between the cities of Firenze, Prato and Empoli, with discos and gay-venues associated-
clusters. A cross-sectional-survey was conducted to assess the prevalence and risk factors for meningococcal-carriage, in
order to address public health interventions.
Methods: A convenience sample of people aged 11–45 years provided oropharyngeal swab specimens and completed
questionnaires on risk factors for meningococcal carriage during a 3months study-period, conducted either in the
outbreak-area and in a control-area not affected by the outbreak (cities of Grosseto and Siena). Isolates were tested by
culture plus polymerase chain reaction. Serogroup C meningococcal isolates were further characterized using multilocus
sequence typing. Univariate and multivariate analyses were performed to estimate adjusted odds ratios (AORs) for
meningococcal carriage.
Results: A total of 2285 oropharyngeal samples were collected. Overall, meningococcal carriage prevalence
was 4.8% (n = 110), with nonencapsulated meningococci most prevalent (2.3%; n = 52). Among encapsulated
meningococci, serogroup B was the most prevalent (1.8%; n = 41), followed by serogroup Y (0.5%; n = 11) and
serogroup C (0.2%; n = 4); one carrier of serogroup E and one of serogroup Z, were also found (0.04%). Three
individuals from the city of Empoli were found to carry the outbreak strain, C:ST-11 (cc11); this city also had
the highest serogroup C carriage prevalence (0.5%). At the multivariate analyses, risk factors for meningococcal
carriage were: illicit-drugs consumption (AOR 6.30; p < 0.01), active smoking (AOR 2.78; p = 0.01), disco/clubs/parties
attendance (AOR 2.06; p = 0.04), being aged 20–30 years (AOR 3.08; p < 0.01), and have had same-sex
intercourses (AOR 6.69; p < 0.01).
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Conclusions: A low prevalence of meningococcal serogroup C carriage in an area affected by an outbreak due to the
hypervirulent N. meningitidis serogroup C ST-11 (cc11) strain was found. The city of Empoli had the highest attack-rate
during the outbreak and also the highest meningococcal serogroup C carriage-prevalence due to the outbreak-strain.
Multivariate analyses underlined a convergence of risk factors, which partially confirmed those observed among
meningococcal outbreak-cases, and that should be considered in targeted immunization campaigns.
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Background
Neisseria meningitidis is an obligate human commensal
bacteria that colonizes the nasopharynx [1]. Colonization
is a prerequisite for transmission and for developing in-
vasive meningococcal disease (IMD). However, IMD is a
rare consequence of invasion and in most individuals
the colonization leads to a period of asymptomatic car-
riage after which N. meningitidis is naturally cleared, de-
termining a serogroup-specific antibody response that
acts as transitory immunization event [2].
Asymptomatic meningococcal carriage is recognized as
an age-dependent phenomenon, with prevalence increas-
ing through childhood from 4.5% in infants to a peak of
23.7% in 19-year olds and subsequently decreasing in
adulthood to 7.8% in 50-year olds [3]. However, in closed/
semi-closed settings and during outbreak-situations, the
carriage rate may be higher [2].
The duration of the carriage state varies; it may be
chronic, lasting for several months, intermittent or transi-
ent, and depends on the properties of the colonizing-
strain [2]. One strain, the sequence-type 11 (ST11)
clonal-complex (cc11) meningococci bearing serogroups
C or W polysaccharide capsules, is recognized to have a
high transmission and recovery rate to balance its short
duration of carriage and inability to create a commensal
relation with the host [4].
In Italy, the incidence rate (IR) of IMD is among the
lowest in Europe [5, 6]. Until 2014, serogroup B was the
main cause of IMD in the country; from 2015, serogroup
C began predominating, determining the 44 and 43% of
all IMD-cases in Italy in 2015 and 2016, respectively.
This sharp increase was driven by the Tuscany re-
gion that contributed for 48.4% (31/64) and 37.5%
(30/80) of all IMD serogroup C cases (MenC) at na-
tional level in 2015 and 2016, respectively [6, 7]. The
increased incidence of MenC reported by Tuscany
was due to a clonal expansion of the hyper-virulent
N. meningitidis strain C:P1.5–1,10–8:F3–6:ST-11(cc11)
[8], which mainly affected the age group 20–30 years,
men who have sex with men, and the area located be-
tween the cities of Firenze, Prato and Empoli, with
discos and gay-venues associated-clusters [9]. As a
consequence, in May 2015, a reactive immunization
campaign offering a single dose of meningococcal
serogroup C conjugate vaccine (MCC) or quadrivalent
meningococcal conjugate vaccine (ACWY) to people
aged 11–45 years, was implemented in Tuscany with
the support of the Italian Ministry of Health (MoH).
In addition, a targeted immunization programme for
MSM was performed in late 2016.
Moreover, with the support of Italian National Insti-
tute of Health (Istituto Superiore di Sanità - ISS), the
Tuscany Region conducted an outbreak investigation
[9], and a cross-sectional carriage survey, whose re-
sults are presented in this paper. The primary
objectives of the survey were to estimate the menin-
gococcal carriage prevalence during the outbreak and




Tuscany is a region located in central Italy with about
3.8 million of inhabitants at the beginning of 2016, and
the capital city is Florence [10].
MCC was introduced in Tuscany in 2006 with a single
dose at 13–15 months of age, and a catch-up program
was implemented in 2007 among those aged 11–20 years
using ACWY. In addition, the Region introduced in
2017 a booster dose of MCC at 6–9 years of age.
The outbreak-response immunization programme was
implemented in the whole Region through mass-media
communications. People eligible for MCC/ACWY (aged
11–45 years) adhered to the campaign by going directly
to immunization clinics.
As of 31st December 2017, vaccine coverage was 90.6%
at 24months of age, 53.6% in the age group 11–20 years,
and 36.6% of the reactive vaccination campaign.
Study design, sample size and sampling
This is a cross-sectional carriage survey conducted dur-
ing the period March 1, 2016–June 30, 2016. The
planned sample size of the study was of 2400 partici-
pants. Assuming a carriage prevalence of 18% [11, 12],
this sample size had a precision of about 1.5% [i.e., the
95% Confidence Interval (95% CI) would have a range of
about 3%]; in the worst case (i.e., carriage prevalence of
50%) the precision would be of about 2%. Recruiting
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occurred in four immunization clinics in the context of
the immunization response campaign: two clinics,
respectively located in the cities of Florence and Empoli
(outbreak-area), and two in the cities of Grosseto and
Siena (control-area). Individuals aged 11–45 years who
presented at immunization clinics to adhere to the
response campaign, were asked to participate in the
study by the health personnel (Public Health Nurses).
Specimen and data collection
A written informed consent form was signed by each
participant, and consent was also obtained from parents/
guardians of subject aged less than 18-years. After sample
collection (done before vaccination), the recruited filled-in
a self-administered questionnaire collecting demographic
information and data on known risk factors for meningo-
coccal carriage (e.g. alcohol-consumption and drinks-shar-
ing, active and passive smoking, illicit-drugs use, disco
attendance etc.) [13–17].
Oropharyngeal swab samples through the mouth were
taken by Public Health Nurses of the vaccination clinic
from the posterior wall of the oropharynx [18] and were
immediately placed in a Copan Liquid Stuart’s swab [19]
and transported within 4 h to the Clinical Microbiology
and Virology Unit of Careggi University Hospital of
Florence for culture, and immediately afterwards, to the
Laboratory of Immunology and Infectious Diseases at
the Anna Meyer Children’s University Hospital of Flor-
ence for polymerase chain reaction (PCR).
Microbiological analyses
Samples were plated on Thayer-Martin agar and Choc-
olate agar (bioMeriéux, Marcy l’Étoile, France) using a
Wasp processorTM (Copan Diagnostics Inc., Brescia,
Italy) and incubated at 35 °C in a 5–10% CO2 atmos-
phere, as previously described by Gasparini et al. [20].
Morphological evaluation of bacterial colonies was
performed after 24 and 48 h. All colonies suspected for
being N. meningitidis were identified by MALDI-TOF
(VITEK MS, bioMeriéux). Once confirmed as meningo-
cocci, colonies were subcultured on Chocolate agar to
obtain pure cultures and stored at − 80 °C pending
further investigations. Serogroups were assessed for each
N. meningitidis isolate following the protocol proposed
by the Center for Disease Control and Prevention
(https://www.cdc.gov/meningitis/lab-manual/chpt10-
pcr.html).
DNA from each sample was extracted and purified
using the MagCore Genomic DNA Tissue Kit with auto-
mated Nucleic Acid Extractor HF16 (RBCBioscience,
Taiwan). All samples were tested with real time-PCR
(rt-PCR) for the ctrA gene [21]. Samples positive for ctrA
gene were serotyped using rt-PCR (A, B, C, W, Y) and
End-Point PCR (29E and Z) [22].
The double test (culture and PCR) was performed to
maximize the sensitivity [23]. To assess the circulation
of the outbreak strain, C:ST-11 (cc11), serogroup C
meningococcal isolates were further characterized using
multilocus sequence typing (MLST) according to the
methods of Maiden et al. [24]. Alleles, sequence types
and clonal complexes were assigned using the Neisseria
species MLST database (http://pubmlst.org/neisseria).
Data analysis
Questionnaires and results on carriage status commu-
nicated by laboratories were collected by the Regional
Health Agency of Tuscany, entered into an Excel
database through an optical reader and double
checked by a statistician and an epidemiologist. After
validation, the database was imported into STATA 12
software for data analysis.
Meningococcal carriage prevalence (overall and by
serogroup) was computed and the exact binomial
distribution was used to calculate 95% confidence
intervals (CI).
The association between the study variables and
meningococcal carriage state was assessed through
univariate (Chi-Square Test) and multiple logistic
models. For the latter, we firstly fitted multiple logis-
tic regression models including all variables with a
p-value < 0.20 at the univariate analysis. Secondly,
backward selection was performed and only variables
with a p-value < 0.10 (by the log-likelihood ratio test) were
retained [25]. Age and sex were included in the final
models independently from the estimated p-values at uni-
variate analyses and in the backward selection. Because
some categories had empty cells (i.e. no meningococcal
carriage), in these cases we performed exact logistic re-
gressions to assess the correlation.
Since only 4 serogroup C carriers were found, we used
as outcome variable the carriage status (positive/nega-
tive, 1/0) regardless of serogroup, while the following
were used as independent variables: gender; age-group
(11–19; 20–30; 31–45), place (Siena, Grosseto, Firenze,
Empoli) and month (March, April, May, June) of swab
collection; occupation (grouped in those recognized in
literature at higher risk for meningococcal carriage [13–
17]: students, workers in restaurant/bar/pub/café,
teachers, armed forces, health professionals, and other
occupation); quantity and type of alcoholics consumed
in a week (grouped in low, moderate and high
drinking-risk-level by using the European Commission
classification for alcohol-consumption [26]); active and
passive smoking; and whether in the month before swab
collection the recruited: shared drinks, consumed
illicit-drugs, had sexual intercourses (including intimate
kissing partners) with men and/or women (then grouped
in no-sexual intercourses; heterosexual-intercourses;
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same-sex intercourses), used antibiotics, had upper re-
spiratory tract infections and attended (a) discos/clubs/
parties (b) bar/pub/restaurants (c) other close-groups
(e.g. sporting groups).
Results were expressed in terms of odds ratios (ORs)
and adjusted odd ratios (AORs), with 95% CI. Statistical
significance was set at p-value< 0.05.
Results
A total of 2285 oropharyngeal samples were collected
(95.2% of the planned sample size).
The overall prevalence of N. meningitidis carriage was
4.8% (n = 110; 95% CI 2.0–5.3%), and the majority
carried nonencapsulated meningococci (2.3%; 95% CI
1.7–3.1%). Among encapsulated meningococci, ser-
ogroup B was the most prevalent (1.8%; 95% CI 1.3–
2.4%; n = 41), followed by serogroup Y (0.5%; 95% CI
0.2–0.9%; n = 11) and serogroup C (0.2%; 95% CI 0.0–
0.4; n = 4). One carrier of serogroup E and one of
serogroup Z were also found (0.04%; 95% CI 0.0–0.2%).
At the MLST analysis performed on the 4N. meningi-
tidis serogroup C isolates, three individuals from the city
of Empoli (outbreak-area) were found to carry the
outbreak strain, C:ST-11 (cc11), and one form the city of
Grosseto (control-area) carried a C:ST-41/44 clonal
complex meningococci.
Additional file 1: Table S1 describes the study-popula-
tion showing the meningococcal carriage prevalence by
serogroups, demographic characteristics and risk factors.
Each study centre contributed equally to the sample
size, with serogroup C most prevalent in Empoli (0.5%).
The 4 serogroup C carriers were all aged 11–19 years,
students, and attended disco/clubs/parties in the month
before swab collection.
Participants who shared drinks in the month before
swab collection had a higher serogroups B and C
carriage prevalence (2.7 and 0.4%, respectively) com-
pared with participants who did not (1.2 and 0.0%,
respectively).
Higher carriage prevalence was observed for all
serogroups among illicit-drugs users, with serogroup Y
most prevalent (11.4%).
The majority of smokers carried nonencapsulated
meningococci (7.2%), while the 4 serogroup C carriers
were all exposed to second-hand smoke.
Those who in the month before swab collection had
same-sex intercourses showed a higher meningococcal
carriage prevalence than those who had heterosexual or
had not sexual intercourses, with nonencapsulated men-
ingococci (76.2%) and N. meningitidis serogroups B and
Y most prevalent (76.2, 4.8 and 4.8%, respectively).
Additional file 2: Table S2 shows the results of the uni-
variate and multivariate analyses of factors associated
with meningococcal carriage status.
At the multivariate analysis including variables with
p < 0.20 at the unviariate analysis, factors statistically
significant associated with the risk of being meningo-
coccal carriage were: illicit-drugs consumption (AOR
6.30; 95% CI 2.44–16.32; p < 0.01), active smoking
(AOR 2.78; 95% CI 1.37–5.63; p = 0.01), disco/clubs/par-
ties attendance (AOR 2.06; 95%CI 1.04–4.23; p = 0.04), the
age-group (p < 0.01) but with a significant association only
for those aged 20–30 years (AOR 3.08; 95% CI 1.97–9.79),
as well as having had sexual intercourse (p < 0.01)
but with a significant increased risk only for those
who had same-sex intercourses (AOR 6.69; 95% CI
2.16–20.70).
Similar results were observed at the multivariate ana-
lysis with backward elimination at 10% level, where the
same variables remained correlated with meningococcal
carriage status in the same direction of association.
Discussion
This study shows meningococcal carriage prevalence
and related risk factors during an outbreak due to the
hypervirulent N. meningitidis serogroup C ST-11 (cc11)
strain occurred in Tuscany, Italy, during 2015–2016 [8,
9]. Despite the outbreak, a low prevalence (0.2%) of
serogroup C carriers was found. This finding is consist-
ent with those of previous carriage surveys conducted
during MenC-outbreaks, where serogroup C carriage
prevalence found not to exceed 1%, being 0.3% in
Canada [27], 1.0% in The Netherlands [28], 0.6% in
Spain [29], 1.0% in Denmark [30], and 0.2% in Brazil
[31]. This low serogroup C carriage prevalence during
MenC-outbreaks, could be partially explained both by
the hypothesis of Trotter et al. [32] that serogroup C
strain have a high recovery and transmission rate,
moving quickly through populations while maintaining a
low prevalence, and by the hypothesis of Caugant et al.
[4] that MenC-outbreaks, in particular due to hyperviru-
lent strains (as ST11/cc11), follow their rapid spread in a
specific-population in terms of asymptomatic carriers of
short duration, as suggested by fact that these out-
breaks are characterized by the occurrence of
MenC-cases in different locations of restricted geo-
graphical areas over short periods of time, without
apparent epidemiological links.
Both hypotheses imply that during MenC-outbreaks,
there are population-pockets where transmission occurs
with people becoming serogroup C carrier for a short
period of time. These population-pockets, are difficult to
detect through prevalence-surveys because this study-
design provides a limited snapshot of a population, that
also due to biases, in particular selection-bias, may not
be reliable of the real carriage prevalence [1].
This limit is present in our study, because the con-
venience sample with recruitment at vaccination
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clinics, may have introduced selection biases by
recruiting participants who were not in the affected
population-pockets.
Moreover, the reactive vaccination campaign with
MMC/ACWY, started 1-year before the study may have
reduced the serogroup C meningococcal carriage preva-
lence, since meningococcal serogroup C conjugate
vaccines have demonstrated a positive impact on redu-
cing the carrier rate [33]. Despite this, it should be of
note, that before, during and after this study, the
MenC-outbreak in Tuscany continued to occur [9],
suggesting that the bacterium was still circulating within
specific population-pockets not surveyed.
On the other hand, a higher carriage prevalence
due to nonencapsulated and serogroups B, Y menin-
gococci was found, as in the aforementioned studies
conducted during MenC-outbreak situations [27–31],
indicating a more commensal behaviour and a longer
duration of the carriage status, that facilitates the
identification of people carrying these strains during
carriage surveys [4, 32].
Differences in the meningococcal prevalence by ser-
ogroups, demographic characteristics and risk factors of
the study population were observed.
In particular, according to the 2015–2016 MenC
outbreak-investigation conducted by Miglietta et al. in
Tuscany [9], where clusters were recognized among
teenagers attending discos, the 4 serogroup C carriers
were all aged 11–19 years and attended discos/club/par-
ties during the month before swab collection. On the
other hand, in contrast with the result of the outbreak-
investigation, where an involvement of the MSM-com-
munity was also identified, none of the serogroup C car-
riers reported MSM-behaviour. This mismatch may be
due to the low number of serogroup C carriers found
that did not allow to clearly identify risk factors for ser-
ogroup C carriers during the outbreak, also determining
the need to group all the serotypes together for the risk
factors analyses.
Higher serogroup C carriage prevalence was observed
in the city of Empoli; in line with this finding, this city
was the one with the higher attack-rate during the
2015–2016 MenC-outbreak [9, 34]. In addition, the fact
that the 3 carriers of the outbreak-strain (C:ST-11/cc11)
were all from the city of Empoli and the one carrying a
C:ST-41/44 clonal complex meningococci was found in
Grosseto (control-area), strongly confirm the circulation
of the outbreak-strain in the affected area.
Overall, risk behaviours identified through multivariate
analyses confirmed what reported in the literature from
carriage surveys. The age group 20-to-30 years was at
increased risk for meningococcal carriage during out-
breaks occurred in The Netherlands, Turkey, Wales, and
in a Review of carriage studies conducted in Europe, and
this is likely due to the convergence of risk behaviours
among young adults [2, 15, 27, 28].
IMD-outbreaks were reported among illicit-drugs
users in the United States (US) [35, 36] and this was a
risk behaviour for meningococcal carriage reported in
other surveys [14, 17]. The mechanisms through which
illicit-drug use may contribute to carriage, meningococ-
cal transmission, or development of IMD are unknown:
sharing illicit-drugs and cannabis-cigarettes use, as well
as prolonged close contact among groups of illicit-drug
users (that may represents population-pockets of menin-
gococcal carriers), is likely to increase the risk [36]. Ac-
tive smoking is a well-recognized risk factor for
meningococcal carriage as well as for other infections
since it causes structural changes in the respiratory tract
and a decrease in immune response [2, 4, 13, 17].
Meningococcal outbreaks linked to discos attendance
are reported in the literature [37, 38] and it is also indi-
cated as a risk factor for meningococcal carriage [2, 4,
13, 17]. According to these studies, in addition to the
crowded conditions, several risk behaviours may con-
verge and cumulate in these places, from smoke to
illicit-drug and alcohol use, drinks and cigarettes shar-
ing, as well as intimate kissing with multiple partners.
Higher meningococcal carriage prevalence among
MSM is reported in the literature [39–41], and recently,
several MenC-outbreaks involved gay, bisexual and other
MSM in Europe and US [16, 42]. What promote the
spread of meningococci among this population-group is
partially explained by the high prevalence of risk behav-
iours reported in the literature among MSM that
facilities frequent close-contacts, but also to an unique
mechanism of sexual-transmission or a specific-suscepti-
bility [16, 42].
No significant difference in the risk of being menin-
gococcal carriage was found by place and month of
swab collection. On this regard, the literature shows
contrasting results [27–31], and a clear relation
between meningococcal carriage and IMD-IR has not
yet been established.
Other risk factors for meningococcal carriage reported
in the literature, as alcohol-consumption, drinks-sharing,
bar attendance, upper respiratory infections, antibiotics
consumption, occupation and gender [2, 4, 14–17], were
instead not found associated in our study or associated
only at the univariate analysis.
Limits of this cross-sectional carriage survey are
intrinsic to the study-design [4, 32]; in particular the
convenience sampling at vaccination clinics may have
introduced selection biases, as the general population
might be at lower risk of carriage compared to close
contacts and/or population-pockets where transmis-
sion occurs; however, the swabbing of close-contacts
of MenC-cases in other studies did not find higher
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carriage rates [43, 44], supporting the hypothesis
reported by Trotter et al. of the high recovery rate of
N. meningitidis serogroup C strain [31]. Another limit
of the study is represented by response biases that
may have been introduced in sensitive questions. In
addition the low number of serogroup C carriers
found did not allow to identify specific risk factors
and to clearly compare them with the results of the
outbreak-investigation [9].
On the other hand, strengths of this study are repre-
sented by the good stability and fit of the data of multi-
variate models as indicated by the very similar results
produced. In addition, the combined use of PCR and
culture allowed maximizing the sensitivity.
Conclusions
In conclusion, this study found a low prevalence of
serogroup C carriage in an area of Tuscany affected by an
outbreak due to the hypervirulent meningococcal ser-
ogroup C ST-11 (cc11) strain. Multilocus sequence typing
analyses confirmed the circulation of the outbreak-clone
in the outbreak-area and the risk factors analysis under-
lined a convergence of risk behaviours, partially confirmed
by the outbreak-investigation, which should be considered
in targeted immunization campaigns.
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